The pharmacoeconomics of managing acute agitation in the emergency department: what do we know and how do we approach it?

Expert review of pharmacoeconomics & outcomes research

Volumn 12, Issue 5, 2012, Pages 589-595

  Chan, Esther W ^a   Taylor, David McD ^b   Knott, Jonathan C ^b   Liew, Danny ^b   Kong, David C M ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ACUTE DISEASE; CLINICAL TRIAL (TOPIC); ECONOMICS; EMERGENCY HEALTH SERVICE; HUMAN; METHODOLOGY; PHARMACOECONOMICS; RESTLESSNESS; REVIEW;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLINICAL TRIALS AS TOPIC; ECONOMICS, PHARMACEUTICAL; EMERGENCY SERVICE, HOSPITAL; HUMANS; PSYCHOMOTOR AGITATION; RESEARCH DESIGN;

EID: 84877148617     PISSN: None     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.12.53     Document Type: Review

References (0)